EFTR News and Press, eFFECTOR Therapeutics Inc. From 06/07/23

2023-06-07 08:27:22 ET United Natural Foods ( UNFI ) -24% after Q3 earning release , Mondee Holdings ( MOND ) -24% announces pricing of secondary offering of common stock by selling stockholders. Vaxart ( VXRT ) -23% announces proposed public offe...

2023-06-07 08:22:15 ET eFFECTOR Therapeutics ( NASDAQ: EFTR ) said on Wednesday that the biopharmaceutical company is set to offer 7.8M shares at $1.125 per share in an ~$8.7M registered direct offering. The company has entered into a definitive agreement with a sing...

SOLANA BEACH, Calif. and REDWOOD CITY, Calif., June 07, 2023 (GLOBE NEWSWIRE) -- eFFECTOR Therapeutics, Inc. (NASDAQ: EFTR), a leader in the development of selective translation regulator inhibitors (STRIs) for the treatment of cancer, today announced that it has entered into a definitive agreeme...

2023-05-31 19:47:53 ET This week has seen the stock market flip-flop, including the volatile world of penny stocks . Investors, especially those interested in high-risk, high-reward low-priced stocks, are attentively tracking the developments in Washington. The impending vote on the deb...

SOLANA BEACH, Calif. and REDWOOD CITY, Calif., May 31, 2023 (GLOBE NEWSWIRE) -- eFFECTOR Therapeutics, Inc. (NASDAQ: EFTR), a leader in the development of selective translation regulator inhibitors (STRIs) for the treatment of cancer, announced today that it has closed its previously announced re...

2023-05-29 06:00:00 ET 3 Tools and Techniques for Evaluating Market Sentiment With Penny Stocks Penny stocks, known for their low market price and high growth potential, are an exciting segment of the financial market, particularly in sectors like technology. These low-cost shares can p...

2023-05-26 09:24:28 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Marvell Tech (NASDAQ: MRVL ) stock is soaring higher on Friday as investors react to the company’s earnings report for the first quarter of 2023. Marvell starts off t...

2023-05-26 09:07:27 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Tilray (NASDAQ: TLRY ) stock is falling hard on Friday after the company announced details of a $150 million registered direct offering . The $150 million registered dir...

2023-05-26 09:01:30 ET eFFECTOR Therapeutics ( NASDAQ: EFTR ) jumped ~117% in the pre-market Friday after Stifel upgraded the nano-cap biotech citing interim Phase 2 data for the company's investigational therapy zotatifin as part of a drug combination in patients with breast ca...

SOLANA BEACH, Calif. and REDWOOD CITY, Calif., May 26, 2023 (GLOBE NEWSWIRE) -- eFFECTOR Therapeutics, Inc. (NASDAQ: EFTR), a leader in the development of selective translation regulator inhibitors (STRIs) for the treatment of cancer, today announced that it has entered into a definitive agreemen...